These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18698199)

  • 41. [Sympathomimetics in ADHD. Cardiovascular risks, FDA warns].
    Ostman-Smith I; Dellborg M
    Lakartidningen; 2007 Apr 25-May 1; 104(17):1307. PubMed ID: 17547274
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of the diagnosis and treatment of children with attention deficit hyperactivity disorder in Spain using the Achievable Benchmarks of Care (ABC) technique].
    Martínez-Bermejo A; Moreno-Pardillo DM; Soler-López B
    Rev Neurol; 2008 Nov 1-15; 47(9):451-6. PubMed ID: 18985593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of attention-deficit/hyperactivity disorder symptoms in male children with high-functioning pervasive developmental disorders.
    Matsushima N; Miyawaki D; Tsuji H; Takahashi K; Horino A; Kawaguchi T; Suzuki F; Kiriike N
    Osaka City Med J; 2008 Jun; 54(1):1-10. PubMed ID: 18819260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.
    Pringsheim T; Sandor P; Lang A; Shah P; O'Connor P
    J Dev Behav Pediatr; 2009 Apr; 30(2):115-21. PubMed ID: 19322105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life in parents of children with attention-deficit-hyperactivity disorder in Hong Kong.
    Xiang YT; Luk ES; Lai KY
    Aust N Z J Psychiatry; 2009 Aug; 43(8):731-8. PubMed ID: 19629794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interventions to promote the evidence-based care of children with ADHD in primary-care settings.
    Langberg JM; Brinkman WB; Lichtenstein PK; Epstein JN
    Expert Rev Neurother; 2009 Apr; 9(4):477-87. PubMed ID: 19344300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Gerber MA; Baltimore RS; Eaton CB; Gewitz M; Rowley AH; Shulman ST; Taubert KA
    Circulation; 2009 Mar; 119(11):1541-51. PubMed ID: 19246689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ADHD affects not only children, but also adults.
    Waldman HB; Perlman SP; Chaudhry RA
    J N J Dent Assoc; 2009; 80(1):25-8. PubMed ID: 19441183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response inhibition and attention processing in 5- to 7-year-old children with and without symptoms of ADHD: An ERP study.
    Spronk M; Jonkman LM; Kemner C
    Clin Neurophysiol; 2008 Dec; 119(12):2738-52. PubMed ID: 18951061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ADHD: A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder.
    Bauchner H
    Arch Dis Child; 2000 Jul; 83(1):63. PubMed ID: 10869002
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX; Ma HW; Wan B; Dai XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
    Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
    J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. American Academy of Pediatrics Committee on Communications: Children, adolescents, and television.
    Pediatrics; 1990 Jun; 85(6):1119-20. PubMed ID: 2339038
    [No Abstract]   [Full Text] [Related]  

  • 57. AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart.
    Circulation; 1994 Jul; 90(1):644-5. PubMed ID: 12501831
    [No Abstract]   [Full Text] [Related]  

  • 58. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research.
    Urbina E; Alpert B; Flynn J; Hayman L; Harshfield GA; Jacobson M; Mahoney L; McCrindle B; Mietus-Snyder M; Steinberger J; Daniels S;
    Hypertension; 2008 Sep; 52(3):433-51. PubMed ID: 18678786
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.
    Lipshultz SE; Adams MJ; Colan SD; Constine LS; Herman EH; Hsu DT; Hudson MM; Kremer LC; Landy DC; Miller TL; Oeffinger KC; Rosenthal DN; Sable CA; Sallan SE; Singh GK; Steinberger J; Cochran TR; Wilkinson JD;
    Circulation; 2013 Oct; 128(17):1927-95. PubMed ID: 24081971
    [No Abstract]   [Full Text] [Related]  

  • 60. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al.
    Nicolucci A; De Berardis G; Sacco M; Tognoni G
    Diabetes Care; 2007 Jun; 30(6):e57; author reply e58. PubMed ID: 17526819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.